SCHEMBL7375171

SCHEMBL7375171

CCCc1ccc(S(=O)(=O)C(N)C(N)C(=O)O)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.51
ALDH1A1 P00352 3/20 0.42
KIF11 P52732 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.41
CA1 P00915 5/20 0.41
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CA7 P43166 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CNR2 P34972 1/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL8429982 0.79 CA2 (0.49) CA2ALDH1A1KIF11SMN1; SMN2LMNA
SCHEMBL8861382 0.78 CA12 (0.55) CA2SMN1; SMN2LMNACA1MMP2
SCHEMBL7372085 0.78 CA12 (0.55) CA2SMN1; SMN2LMNACA1MMP2
SCHEMBL382144 0.77 SLC1A2 (0.54) CA2ALDH1A1SMN1; SMN2LMNACA1
SCHEMBL7651611 0.77 SLC1A2 (0.54) CA2ALDH1A1SMN1; SMN2LMNACA1
SCHEMBL7452284 0.76 CA12 (0.45) CA2ALDH1A1LMNACA1MMP2
SCHEMBL8861438 0.76 SLC1A2 (0.41) CA2CA1MMP2MMP9CA12
SCHEMBL9094528 0.76 SLC1A3 (0.58) CA2CA1MMP2MMP9CA14
SCHEMBL8861442 0.76 SLC1A2 (0.41) CA2CA1MMP2MMP9CA12
SCHEMBL7372101 0.76 SLC1A3 (0.58) CA2ALDH1A1CA1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0730590-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-11 EP claimed
WO-1995014683-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-06-01 WO claimed